Application of Caco-2 cell model in drug research

Chinese Pharmacological Bulletin

Volumn 21, Issue 5, 2005, Pages 536-539

  Mu, Yong Ping ^a   Wu, Gang ^a   Zhou, Li She ^a   He, Yan Ling ^a  

^a BAOTOU MEDICAL COLLEGE   (China)

Author keywords

Absorption; Caco 2 cell; Cell model; Drug

Indexed keywords

ANTINEOPLASTIC AGENT; CHINESE DRUG;

ARTICLE; CANCER; CELL MODEL; CELL STRAIN CACO 2; CHINESE MEDICINE; DRUG ABSORPTION; DRUG METABOLISM; DRUG RESEARCH; DRUG TOXICITY; HUMAN; MODEL; NONHUMAN;

EID: 23444449738     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hidlgo LJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability[J]. Gastroenterology, 1989, 96(3):736-49.
2. Vig BS, Lorenzi PJ. Aminoacid ester prodrugs of floxuridine: Synthesis and effects of structure, stereochemistry, and site of esterification on the rate of hydrolysis[J]. Pharm Res, 2003, 20(9): 1381-8.
3. Liang-Shang L, Bridgers G, Dhiren RT. Application of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium[J]. Adv Drug Deliv Rev, 1997, 23(1):77-98.
4. Yee S. In vitro permeability across Caco-2 cells(clonic) can predict in vivo (small intestinal), absorption in man-fact or myth[J]. Pharm Res, 1997, 14(6):763-6.
5. Da Violante G, Zerrouk N, Richard I et al. Evaluation of the cytotoxicity effect of dimethyl sulfoxide(DMSO) on Caco-2/TC-7 colon tumor cell cultures[J]. Biol Pharm Bull, 2002, 25(12):1600-3.
6. Hillgren KM, Kato A, Borchardt RT. In vitro systems for studying intestinal drug absortion[J]. Med Res Reo, 1995, 15(1):83-109.
7. Klimecki WT, Futscher BW, Grogan TM et al. P-glycoprotein expression and function in circulating blood cells from normal Volunteers[J]. Blood, 1994, 83:2451-8.
8. Walle UK, Walle T. Taxol transport by human intestinal epithelial Caco-2 cells[J]. Durg Metab Dispos, 1998, 26(4):343-6.
9. Flicker G, Drewe J, Humyler J et al. Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation[J]. Br J Pharmacol, 1996, 118(7):1841.
10. Yang HT, Wang GJ. Transport and uptake characteristics of a new derivative of berberine (CPU-86017) by humane intestinal epithelial cell line: Caco-2[J]. Acta Pharm Acol Sin, 2003, 24(12): 1185-91.
11. Rosenberg DW, Leif T. Regulation of cytochrome P450 in cultured human colonic cells[J]. Arch Biochem Biophys, 1993, 300:186-92.
12. Lampen A, Bader A, Bextmann T et al. Catalytic activities, protein and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines[J]. Xenobiotica, 1998, 28(5):429-41.
13. Perters WH, Roelofs HM. Time-dependent activity and expression of glutathione S-transferases in the human colon adenocarcinome cell line Caco-2[J]. Biochem J, 1989, 264(2):613-6.
14. Abid A, Bouchou F, Siest G et al. Glucuronidation in the Caco-2 human intestinal cell line: induction of UDP-glucuronosyltransferase 1 * 6[J]. Biochem Pharmacol, 1995, 50(4):557-61.
15. Prueksaritanont T, Gorham LM, Hochman JH et al. Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells[J]. Drug Metab Dispos, 1996, 24(6):634-42.
16. Oprea TJ, Davis AM, Teague SJ et al. Is there a difference between leads and drugs? A historical perspective[J]. Chem Inf Comput Sci, 2001, 41:1308-15.